Navigation Links
Dragon Pharma reports 2010 first quarter financial results
Date:5/17/2010

the Ontario Securities Commission. The full financial statements are also available on Dragon's website at http://www.dragonpharma.com.

Additional Information and Where to Find It

As previously disclosed, the Company has entered into an agreement and plan of merger with Chief Respect Limited, a Hong Kong corporation, Datong Investment Inc., a Florida corporation and a wholly owned subsidiary of Chief Respect Limited, and Mr. Yanlin Han. The Company has filed with the Securities and Exchange Commission (the "SEC") a Schedule 13E-3, and a preliminary proxy statement for the meeting of stockholders of the Company to be convened to approve the merger. BEFORE MAKING ANY VOTING OR INVESTMENT DECISION, THE COMPANY'S STOCKHOLDERS AND INVESTORS ARE URGED TO READ THE PROXY STATEMENT (INCLUDING THE DEFINITIVE PROXY STATEMENT, WHEN IT BECOMES AVAILABLE) AND OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED MERGER. When completed a final proxy statement will be mailed to our stockholders. Investors and stockholders may obtain a free copy of the proxy statement when it becomes available, and other documents filed by us with the SEC, at the SEC's web site at http://www.sec.gov. Free copies of the proxy statement, when it becomes available, and our other filings with the SEC may also be obtained from us. Free copies of our fi
'/>"/>

SOURCE Dragon Pharmaceutical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
2. Strong Demand Pushes up Both Prices and Sales Volumes for Dragons Main Products
3. Dragon Announces R&D Achievement in Biotech Manufacturing Process
4. Dragon announces new product launch; increase in annual production output capacity
5. Dragon retains leading investor relations firm
6. Dragon Pharma announces 2007 full year financial results
7. 3SBio Inc. to Present at The Oppenheimer 2nd Annual China Dragon Call Conference
8. Dragon Pharma Announces June 26, 2008 for 2008 Annual Shareholders Meeting
9. Dragon Pharma Announces Results of the Annual General Meeting
10. Dragon to Present at BioContact Quebec 2008
11. China Biologic Products to Present at CCG IRs China Rising Conference and Oppenheimers China Dragon Call Conference in New York
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... SHENZHEN , Kina, 22. juli ... (BGI Tech), et datterselskab af BGI, verdens største ... human whole exome-sekvenseringstjeneste baseret på Complete Genomics brancheførende ... i branchen for at levere patenterede sekvenseringsteknologier med ... typer varianter, blev købt af BGI i 2013. ...
(Date:7/22/2014)... -- Hussey Copper , a leader in copper ... announces Pullman Regional Hospital,s conversion of more than 1,100 ... surface, at a nominal cost.  This reasonably priced surface ... bacteria within 2 hours of exposure 1 and will ... diseases in its facilities. Pullman Regional Hospital, ...
(Date:7/22/2014)... WA (PRWEB) July 22, 2014 Quorum Review ... new service for large clinical trials called Quick Step™ ... is designed to address the research industry’s need for seamless ... The service is available for studies planning 50 or more ... a combined planned North American site count of 80 or ...
(Date:7/22/2014)... Lawrence, KS (PRWEB) July 22, 2014 ... as attention-deficit hyperactivity disorder (ADHD) is diagnosed, selecting medication ... trial and error. Analyzing brain patterns by using electroencephalography ... best result and thus lower the risk of adverse ... Electroencephalography Phenotypes and Biomarkers” in the current issue ...
Breaking Biology Technology:BGI Tech lancerer Human Whole Exome-sekvenseringstjeneste på Complete Genomics avancerede platform 2Pullman Regional Hospital changes more than 1,100 touch points to Hussey Copper's MD-Cu29 antimicrobial copper to help protect against bacteria 2Pullman Regional Hospital changes more than 1,100 touch points to Hussey Copper's MD-Cu29 antimicrobial copper to help protect against bacteria 3Quorum Review IRB Launches New Quick Step™ Service for Large Clinical Trials 2Quorum Review IRB Launches New Quick Step™ Service for Large Clinical Trials 3Analyzing Brain Patterns with EEG Can Help Predict Effective Use of Medication 2Analyzing Brain Patterns with EEG Can Help Predict Effective Use of Medication 3
... (Nasdaq: CHDX ) a leading independent American provider ... of China,announced that it intends to release its financial ... Thursday, June 12, 2008., Chindex,s management will also ... 9:00 a.m. Eastern Time to discuss its financial results., ...
... Quarter ... Salesforce ... Insulet Corporation,(Nasdaq: PODD ), a leader in wearable insulin ... for,the first quarter ended March 31, 2008., First quarter 2008 ...
... Inc.,(NYSE: HSP ), a global specialty pharmaceutical ... Bowles, CFA, has been elected to,the company,s board ... expertise from leadership positions held at major,multinational consumer ... of Bowles expands Hospira,s board to nine directors, ...
Cached Biology Technology:Chindex International Announces Conference Call to Discuss Its Fiscal 2008 Fourth Quarter and Year End Results on Thursday, June 12, 2008 2Chindex International Announces Conference Call to Discuss Its Fiscal 2008 Fourth Quarter and Year End Results on Thursday, June 12, 2008 3Insulet Reports First Quarter 2008 Results 2Insulet Reports First Quarter 2008 Results 3Insulet Reports First Quarter 2008 Results 4Insulet Reports First Quarter 2008 Results 5Insulet Reports First Quarter 2008 Results 6Insulet Reports First Quarter 2008 Results 7Hospira Expands Board of Directors 2
(Date:7/22/2014)... you,re allergic to dust mites (and chances are you ... at the University of Iowa have developed a vaccine ... body,s immune response. In animal tests, the nano-sized vaccine ... exposure to the allergens, according to the paper, published ... Scientists) Journal . One big reason why it ...
(Date:7/22/2014)... be on the horizon. Bacteria that produce a ... insulin resistance and other adverse effects of a ... discovered., "Of course it,s hard to speculate from ... Ph.D., assistant professor of Pharmacology. "But essentially we,ve ... in mice, even though they,re eating a high-fat ...
(Date:7/22/2014)... The challenges faced by researchers in modifying properties of ... a simple technique, thanks to recent innovative studies conducted ... , Through the use of a simple, efficient and ... NUS research teams, led by Professor Sow Chorng Haur ... of Science, demonstrated that the properties of two different ...
Breaking Biology News(10 mins):Researchers create vaccine for dust-mite allergies 2Vanderbilt study shows therapeutic bacteria prevent obesity in mice 2NUS scientists use low cost technique to improve properties and functions of nanomaterials 2NUS scientists use low cost technique to improve properties and functions of nanomaterials 3
... has shown that enhancing the production of a protein ... neuron death associated with Alzheimer,s, at the expense of ... amyloid-beta protein plaques within the brain is a major ... contribute to disease progression. Normally, special enzymes chew up ...
... peas to show that one copy of a gene (allele) is ... the progeny, the inherited genes are expressed at the right time ... that although gene products could be modified during the life of ... Now it appears that one copy of some genes ...
... ARLINGTON, Va., June 10 Stanley, Inc. (NYSE:,SXE), ... services,to the U.S. federal government, announced today that ... Oberon Associates, Inc. (Oberon), an,engineering, intelligence operations and ... approximately $170 million in cash,subject to certain working ...
Cached Biology News:Genome communication 2Genome communication 3Genome communication 4Stanley to Acquire Oberon Associates 2Stanley to Acquire Oberon Associates 3Stanley to Acquire Oberon Associates 4
... an automated multiplexing platform that uses advanced ... sequence detection and pharmacogenetics applications. Multiple samples ... an open and flexible electronic microarray, the ... all tests sites have been utilized. This ...
The Bio-Plex Manager version 3.0 to 4.0 workstation software upgrade kit is used to upgrade existing Bio-Plex Manager version 3.0 software to version 4.0 security edition software....
... siRNA --- a cocktail of 3 siRNAs ... interestis our most popular product. The siTrio ... knockdown of your target gene when used ... transfection and confirmation of optimal transfection with ...
... D kit is an enzymeimmunoassay intended ... D (25-OH D) and other hydroxylated ... Our patented DIRECT assay technology eliminates ... centrifugation and therefore facilitates automation on ...
Biology Products: